StonvexLoading…
StonvexStonvexStonvexCore line items from CRON's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $45.21M | $146.59M | $102.06M | $65.72M |
Operating Income | $-1.83M | $-17.39M | $-9.90M | $-9.40M |
Net Income | $13.75M | $-9.45M | $-7.63M | $-33.59M |
EPS (Diluted) | $0.04 | $-0.02 | $-0.02 | $-0.09 |
Total Assets | $1.17B | $1.20B | $1.18B | $1.18B |
Total Liabilities | $48.30M | $54.18M | $46.36M | $45.02M |
Cash & Equivalents | $821.86M | $791.79M | $784.17M | $794.42M |
Free Cash Flow OCF − CapEx | $9.02M | $149.00K | $-9.55M | $-18.37M |
Shares Outstanding | 376.26M | 381.59M | 382.89M | 383.81M |